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Abstract
Background Transanal total mesorectal excision (TaTME) was introduced in 2009 as a dedicated approach for the treat-
ment of mid-low rectal cancer. We aimed to describe and discuss the learning curve for 121 consecutive TaTME procedures 
performed by the same team.
Methods The primary outcome was the number of operations required to decrease the mean operative time (mOT). The 
secondary outcomes were the number of operations required to decrease the major complication (MC) rate, the anastomotic 
leakage (AL) rate, the clinical anastomotic failure rate, and the reoperation rate. A cumulative sum (CUSUM) curve analysis 
was used to identify the inflection points. As an integrative analysis, Bernoulli CUSUM curves, risk-adjusted CUSUM curves 
based on the observed-expected outcomes, and CUSUM curves targeting results reported in the literature were created.
Results Seventy-one cases were needed to overcome the OT learning curve sufficiently to reach mastery. The MC and 
reoperation rates started to decrease after the 54th case and further decreased after the 69th case. The AL rate started to 
decrease after the 27th case and remained stable at 5–5.1%. The comparison between the different phases of the learning 
curves confirmed these turning points.
Conclusions TaTME had a learning curve of 71 cases for the mOT, 55–69 cases for MCs and reoperation, and 27 cases for 
AL. According to our results, attention should be paid during the first part of the learning curve to avoid an increased rate 
of MCs and AL.
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Rectal resection with total mesorectal excision (TME) is 
accepted as the surgical standard for the treatment of rectal 
cancer [1, 2]. The non-inferiority of laparoscopic compared 
to open TME in terms of disease-free survival (DFS) has 
been demonstrated in the phase III COREAN and COLOR 
II trials [3, 4]. However, two recent randomized controlled 
trials (RCTs) failed to demonstrate the non-inferiority of the 
minimally invasive approach compared to the open approach 
in terms of pathological results [5, 6]. Laparoscopic TME 
is associated with increased surgical difficulty when some 
clinical and anatomical factors, such as a high BMI, a nar-
row pelvis, or bulky or very low tumors, are present. For 
this reason, transanal total mesorectal excision (TaTME) has 
been proposed as a dedicated approach for the treatment 
of mid and low rectal cancers [7]. Since its introduction in 
2009, there has been a lively debate around TaTME. In cent-
ers where TaTME is routinely performed, short- and long-
term results have been reported as non-inferior to those of 
laparoscopic TME, with advantages in terms of short-term 
outcomes, such as postoperative complications and readmis-
sion, and non-inferiority in terms of long-term oncological 
outcomes [8]. However, there have been some reports of 
specific surgical complications associated with TaTME (ure-
thral injuries, pelvic wall injuries, carbon dioxide embolism, 
nerve damage) [9, 10]. A more worrisome issue is the unex-
pectedly high rate of early locoregional recurrence reported 
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in two studies analyzing oncological outcomes in the early 
phase of TaTME implementation [10, 11]. In light of these 
reports, the need for standardized surgical education and 
proper training in this technique have been advocated [12]. 
Theoretically, patients’ clinical outcomes are supposed to 
be related to surgeons’ experience with a specific proce-
dure, and the definition of a learning curve is imperative to 
define the number of procedures to be strictly monitored and 
supervised before reaching proficiency. To date, only three 
observational studies have reported a learning curve analysis 
in TaTME [13–15].
Analyzing different outcomes, these papers identified a 
cutoff point of 40 cases for improved postoperative short-
term results [13], 45–51 cases for high-quality pathological 
specimens [14], and 50 cases for reducing the anastomotic 
leakage (AL) rate [15]. However, due to some heterogeneity 
in the case series and the small number of studies in the liter-
ature, the learning curve for TaTME is not yet standardized.
At Fondazione Policlinico Universitario A. Gemelli 
IRCSS (Rome, Italy), TaTME has been routinely used to 
treat mid-low rectal cancer since 2015 [16]. The aim of this 




One hundred twenty-eight patients underwent elective 
TaTME for rectal cancer between 30 April 2015 and 31 
December 2019 at Fondazione Policlinico Universitario A. 
Gemelli IRCCS, Rome. All patient data were included in 
a prospectively recorded institutional database and retro-
spectively analyzed for the purposes of this study. Patients 
considered eligible for this study were adults with mid-low 
rectal neoplasms undergoing elective TaTME. Patients 
undergoing transanal rectal resection for inflammatory 
bowel disease (n = 5) and patients undergoing TaTME in 
reoperation for locoregional recurrence after previous rectal 
resection (n = 2) were excluded from the study cohort. The 
Institutional Review Board/Ethical committee approved this 
study (approval number is 2760906—Current Research Pro-
ject registered in the Italian Research Workflow).
Data collection
Data were retrospectively collected from the institutional 
database. The collected data included sex, age, BMI, previ-
ous abdominal surgery, Charlson comorbidity index (CCI), 
ASA score, preoperative tumor stage, preoperative neoad-
juvant treatment, preoperative hemoglobin, preoperative 
albumin, distance of the tumor from the anorectal junction 
(measured by magnetic resonance imaging (MRI)), opera-
tive time (OT), type of colorectal reconstruction, creation of 
diverting ileostomy, tumor dimension, p/yp stage, distance 
from the distal margin on pathological staging, circumfer-
ential resection margin (CRM) status, postoperative stay, 
30-day postoperative complications (all postoperative com-
plications, reoperation, readmission and mortality), presence 
of early and late AL, anastomotic stenosis, and follow-up 
data (overall survival (OS), local and distant DFS). The 
tumor stage was determined according to the 8th edition of 
the AJCC-TNM classification [17]. Thirty-day postoperative 
morbidities were classified according to the Clavien–Dindo 
classification [18]; major postoperative complications were 
defined as complications of grade 3 to 5. Thirty-day postop-
erative readmission was considered a postoperative compli-
cation scored according to the Clavien–Dindo classification. 
Postoperative leakage was defined according to the defini-
tion provided by the International Study Group of Rectal 
Cancer [19]. Clinical anastomotic failure was defined as 
clinically relevant AL or stenosis requiring re-anastomosis 
or a definitive stoma, while anastomotic failure was defined 
according to the definition of Penna et al. [9]. A positive 
CRM was defined as a CRM < 1 mm. The local recurrence 
rate was calculated in patients with a minimum follow-up 
of 24 months.
Surgical technique and perioperative management
The abdominal procedure was performed as a laparoscopic 
rectal resection procedure, namely, a 3/4 trocar technique 
that included central vascular ligation, mobilization of the 
splenic flexure, medial to lateral mesocolic mobilization and 
incision of the pelvic peritoneal reflection. The transanal 
procedure was performed as previously described [16]. All 
surgical procedures were performed by the same surgical 
team. The first eight procedures were performed using a 
single-team approach, while from the ninth case on, a syn-
chronous double-team approach was adopted. All patients 
followed a standardized perioperative enhanced recovery 
after surgery (ERAS) protocol [20].
Oncological management
Initial tumor staging was performed using thoracoabdomi-
nal computed tomography (CT) and pelvic MRI. Patients 
with locally advanced rectal cancer (cT3-T4, nodal involve-
ment) were treated with neoadjuvant chemoradiotherapy. 
After neoadjuvant therapy, patients were locally restaged 
by MRI. Surgery was performed at a minimum of 8 weeks 
after the end of radiotherapy. After surgery, according to the 
pathological staging, patients received a postoperative evalu-





The primary outcome of this study was the number of opera-
tions required to decrease the mean operative time (mOT). 
The secondary outcomes were the number of operations 
required to decrease the postoperative stay, the postoperative 
complication rate, the major complication (MC) rate, the AL 
rate, the anastomotic failure rate, the reoperation rate, and 
the readmission rate, with characterization of the different 
learning curves and comparison of the learning curves for 
every outcome.
Statistical analysis
The learning curve analysis was performed accord-
ing to the cumulative sum CUSUM method to explore 
the relationship between the primary outcomes and the 
sequence number of the TaTME procedure [21]. The 
simple CUSUM series was defined for every case as 
 CUSUMn = ∑(Xn – X0) + CUSUMn-1, where Xn represents 
the individual measurement, and X0  is a predetermined 
reference level. X0 was set as the mean for all cases in the 
first analysis. The CUSUM score was plotted against the 
sequence of operations. The inflection point of the learning 
curve was defined as the point where the curve started to 
descend gradually and was considered the end of the learn-
ing curve [22].
As a complement to the CUSUM series, a two-sided Ber-
noulli CUSUM chart was plotted to detect consistency with 
the mean or “alarm signals” in the surgical performance [23]. 
The point at which the OT became consistent with the mean, 
without further significant changes in terms of the mOT, 
was defined as the point of “mastery” of the technique [22]. 
The control limits for the “alarm signals” were set at ± 4*σD 
(σD = standard deviation). The Bernoulli  CUSUMmax and 
 CUSUMmin were defined as  CUSUMmaxn = max (0, Xn –  i0 + 
σD/2 + CUSUMmaxn-1), where the max (0,) yields 0 when 
a negative value is calculated, and  CUSUMminn = min (0, 
Xn – X0—σD/2 + CUSUMmaxn-1), where the min (0,) yields 0 
when a positive value is calculated.
Then, to account for possible patient-related confound-
ers, a risk-adjusted CUSUM (RA-CUSUM) analysis based 
on observed-expected (O–E) statistics was performed [24]. 
A set of multivariate regression analyses was conducted for 
every outcome. For linear regressions (dependent variables: 
OT, postoperative stay), a backward selection model was 
applied, while for logistic regressions, a backward (depend-
ent variable: postoperative complications) or forward 
(dependent variables: MCs, AL, anastomotic failure, reoper-
ation, readmission) selection model was applied, according 
to the number of events per outcome. The risk scores for the 
expected outcomes were calculated according to the constant 
and the regression coefficients of the variables in the final 
model. For the logistic regression equation, a conversion 
from odds ratios (ORs) to risk probability coefficients was 
performed according to the following formula p = exp(OR)/
[1 + exp(OR)]. The risk scores derived from the regression 
equations were substituted for X0 for every single case in the 
CUSUM equation. A two-sided Bernoulli CUSUM chart 
was plotted for these results using the σD of the observed 
outcome [25].
Last, a second simple CUSUM analysis where  X0 was 
set as the specific mean reported in the literature was per-
formed. The paper by Penna et al. [9] reporting data from the 
International TaTME Registry was used as a reference for 
the positive distal margin (0.7%)/positive CRM rate (4.1%), 
the postoperative complication rate (35.2%), the MC rate 
(13.2%), the AL rate (9.8%), and the reoperation rate (8%).
Patients were then divided into early-experience and 
late-experience groups according to the cutoff points of the 
CUSUM graphs. Quantitative data are reported as either 
the mean ± standard deviation (range) or median ± range. 
Continuous variables were analyzed using Student’s t test 
or ANOVA. Qualitative data are reported as the number of 
patients (percentage of patients) and were compared with 
Pearson χ2 or Fisher’s exact test.
All analyses were performed using Microsoft Office Excel 
and IBM SPSS, version 23 (IBM Co., Armonk, NY, USA). 
All tests were 2-sided with a significance level set at 0.05.
Results
In this study, 121 consecutive patients were selected for the 
learning curve analysis according to the inclusion and exclu-
sion criteria. The clinicopathological characteristics of the 
entire cohort are reported in Table 1. The equations obtained 
from the linear and logistic regression analyses used for the 
RA-CUSUM O-E analysis are presented in Table 2. No 
RA-CUSUM analysis was performed for the positive CRM 
rate due to the small number of positive cases (n = 3). The 
CUSUM curves are presented in Figs. 1, 2, and 3.
CUSUM charts for the surgical outcomes
OT (Fig. 1A–D)
The mOT in the cohort was 284 ± 54 min. The CUSUM 
analysis identified an initial phase of increase up to the 
18th procedure, then a decrease down to the 30th proce-
dure, followed by a second increase up to the 54th pro-
cedure. Then, there was a plateau phase until the 87th 
procedure, followed by a progressive decrease in the mOT. 
The RA-CUSUM O-E analysis identified a similar pattern 
with a peak up to the 54th case, a temporary decrease 
followed by a moderate increase, and then a consistent 
 Surgical Endoscopy
1 3
Table 1  Clinicopathologic, 
operative, and short-term 
outcomes of 121 patients 
undergoing TaTME
Variable Values




BMI, kg/m2, mean ± SD (range) 25.2 ± 3.9 (14–41)





Hemoglobin, g/dl, mean ± SD (range) 12.8 ± 1.8 (8.9–17.6)









Height of the tumor from anorectal junction determined at the MRI
  ≤ 50 mm 57 (47.1%)
  > 50 mm ≤ 100 mm 61 (50.4%)
  > 100 mm 3 (2,5%)












Operative time, min, mean ± SD (range) 284 ± 58 (180–440)
Combined approach
 Yes (two teams) 113 (93.4%)










Tumor max size, mm, mean ± SD (range) 28 ± 19 (0–150)




*Calculated on 108 patients with CR anastomosis
Table 1  (continued) Variable Values
 Yes 4 (3.3%)
 No 117 (96.7%)
Quality of specimen (Quirke) Complete 107 (88.4%)
Nearly complete 11 (9.1%)
Incomplete 3 (2.5%)
Evaluated lymph nodes, mean ± SD (range) 12 ± 5 (0–26)
p/yp Stage


































Table 2  Equations for the calculation of the expected outcomes derived from the linear and logistic regression analyses
Operative time (min)  = 190.967 + (− 29.89 * Female Sex) + (2.522 * BMI) + (21.786 * Node Positivity) + (41.314 * 
Diverting Ileostomy)
Postoperative complications (OR)  = 2.723 + (− 1.362 *  Neoadjuvant Therapy) + (0.194 * Charlson Index) + (0.007* Operative Time)
Major complications (OR)  = − 13.792 + (0.446 * Charlson Index) + (0.312 * BMI)
Reoperation (OR)  = − 11.507 + (0.314 * Charlson Index) + (0.249 *  BMI)
Anastomotic leakage (OR)  = − 9.62 + (0.102 * Age)
Clinical anastomotic failure (OR)  = − 1.792 + (− 1.626 * Neoadjuvant Therapy)
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decrease in the mOT after the 87th procedure. The Ber-
noulli CUSUM charts detected a mOT above the upper 
control limit until the 19th procedure. “Mastery” of the 
procedure was reached at the 71st procedure.
Postoperative complications (Fig. 2A–E)
The rate of postoperative complications was 36.3%. The 
CUSUM analysis identified an initial phase of increasing 
Fig. 1  CUSUM curves associated with operative time. A Simple 
CUSUM curve, B Bernoulli Cumulative Deviation Curves for sim-
ple CUSUM, C RA-CUSUM curves, and D Bernoulli Cumulative 
Deviation Curves for RA-CUSUM. CumDevPosit Cumulative sum of 
the positive deviations, CumDevNeg Cumulative sum of the negative 
deviations, CumDevMean mean of the CumDevPos and CumDevNeg 
values
Fig. 2  CUSUM curves associated with postoperative complications 
and major complications. A–F simple CUSUM curve, B–G Ber-
noulli Cumulative Deviation Curves for simple CUSUM, C–H RA-
CUSUM curves, D–I Bernoulli Cumulative Deviation Curves for 
RA-CUSUM, and E–J simple CUSUM curve using a reference mean 
from the literature. CumDevPosit cumulative sum of the positive 
deviations, CumDevNeg cumulative sum of the negative deviations, 
CumDevMean mean of the CumDevPos and CumDevNeg values
Fig. 3  CUSUM curves associated with anastomotic leak, clinical 
anastomotic failure, and anastomotic failure. A–F simple CUSUM 
curve, B–G Bernoulli Cumulative Deviation Curves for simple 
CUSUM, C–H RA-CUSUM curves, D–I Bernoulli Cumulative Devi-
ation Curves for RA-CUSUM, and E–J simple CUSUM curve using 
a reference mean from the literature. CumDevPosit cumulative sum of 
the positive deviations, CumDevNeg cumulative sum of the negative 




postoperative complications up to the 24th procedure, fol-
lowed by a plateau to the 69th procedure, a progressive 
decrease down to the 85th procedure, a second increase up 
to the 96th procedure, and then a decrease. The RA-CUSUM 
analysis identified an increase up to the 24th procedure, fol-
lowed by a plateau to the 69th procedure, and then a pro-
gressive decrease. The Bernoulli CUSUM charts detected a 
postoperative complication rate above the upper control limit 
for the 21st procedure. Comparison with the values of the 
International TaTME Registry showed a long plateau phase 
from the 24th to the 108th procedure, with peaks at the 69th 
and 96th procedures.
MCs (Fig. 2F–J)
The MC rate was 7.4%. The CUSUM analysis identified a 
progressive increase in the curve up to the 54th procedure. A 
second lesser peak was detected at the 69th procedure. The 
RA-CUSUM analysis identified a peak at the 54th proce-
dure, followed by a decrease. The Bernoulli CUSUM charts 
identified a MC rate that was above the upper control limit 
from the 53rd to the 55th procedure. Comparison with the 
values of the International TaTME Registry showed a turn-
ing point at the 54th procedure.
Reoperation (Supplementary Fig. 1sa–e)
The reoperation rate was 5.8% (7 patient). The reasons of the 
reoperations were as follows: in 1 patient a complete disrup-
tion of the anastomosis that required an abdominoperineal 
resection; in 2 patients ischemia of the anastomotic descend-
ing colon that required resection and terminal colostomy; in 
2 patients a malfunction of the ileostomy that required revi-
sion; in 1 patient small bowel injury that required explora-
tory laparoscopy and suture; and in 1 patient early postoper-
ative bowel obstruction due to a internal hernia that required 
exploratory laparotomy. The reoperation rate increased up 
to the 22nd procedure and then presented a plateau phase 
with a higher peak at the 69th procedure and a turning point 
at the 89th procedure. The RA-CUSUM analysis identified 
a progressive increase up to the 54th procedure and then a 
progressive decrease. The Bernoulli CUSUM charts identi-
fied a reoperation rate that was above the control limit from 
the 18th to the 31st procedure in the unadjusted graph and 
for the 22nd and 23rd procedures in the O-E statistic-based 
graph. Comparison with the values of the International 
TaTME Registry showed a peak at the 22nd procedure, a 
plateau and a then turning point at the 69th procedure.
AL (Fig. 3A–E)
The AL rate was 10.2%. The rate of AL increased up to the 
27th case and then started to decrease, presenting a second 
peak up to the 47th procedure, followed by a progressive 
decrease. At the 78th procedure, there was another minor 
peak, followed by a decrease. The RA-CUSUM analysis 
was consistent with the previous analysis. The Bernoulli 
CUSUM charts detected an AL rate that remained above the 
control limit from the 16th to the 42nd procedure. The com-
parison with the values of the International TaTME Registry 
was consistent with the previous analyses.
Clinical anastomotic failure (Fig. 3F–J)
The rate of clinical anastomotic failure was 6.5%. The rate 
of clinical anastomotic failure increased up to the 27th case 
and then presented two minor peaks at the 47th and 78th 
cases. The RA-CUSUM analysis identified a peak at the 27th 
case and then a substantial decrease in the curve below the 
reference limit. The Bernoulli CUSUM chart detected an 
AL rate above the control limit from the 18th to the 29th 
procedure and from the 78th to the 80th procedure, while the 
O-E Bernoulli CUSUM chart described a curve below the 
control limit for all cases. Comparison of the anastomotic 
failure rate according to the definition of the International 
TaTME Registry [9] was 11.1% and showed a peak at the 
27th procedure, followed by a progressive decrease.
Comparisons between the clinical outcomes 
in the different learning phases
According to the visual analysis of the learning curves, cut-
off points were defined at the turning point for the OT at the 
54th and 87th procedures, for MCs and reoperation at the 
54th and 69th procedures, and for AL at the 27th and 47th 
procedures. Comparison of the OT among the three phases 
(1–54, 54–87, 88–121) confirmed a significant difference 
and a progressive decrease in the OT (300 ± 59 vs 283 ± 58 
vs 259 ± 46, p = 0.005). The rate of postoperative compli-
cations was significantly decreased from the first phase to 
the second phase using both the 54th and 69th procedure 
as turning points (p = 0.041 and p = 0.024, respectively). 
The rates of MCs, reoperation and readmission showed 
no significant differences, both using the 54th (p = 0.076, 
p = 0.240 and p = 0.067, respectively) and the 69th procedure 
(p = 0.076, p = 0.237, p = 0.055) as turning points. However, 
the crude rates of postoperative complications (46.3% vs. 40 
vs. 25%), MCs (13% vs 6.7% vs 1.9%), reoperation (9.3% vs 
6.7% vs 1.9%), and readmission (18.5% vs 13.3% vs 5.8%) 
all decreased from the early (1–54) to the middle (55–69) 
and late (70–121) phases, respectively.
Patients in the early (1–54) and middle-late (55–121) 
phases demonstrated a higher CCI (p = 0.040), a lower pre-
operative hemoglobin level (p = 0.009) and a higher rate of 
treatment with neoadjuvant radio-chemotherapy (p = 0.016) 
(Supplementary Fig. 2sa–c). Instead, after the 69th case, 
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no difference in the CCI or hemoglobin level was detected. 
Comparison of the early (1–27) and the late phase (28–121) 
of the CUSUM curve for AL identified a significantly dimin-
ished rate of AL in the late phase (25.8% vs 5%, p = 0.005). 
The risk of clinical anastomotic failure was not significantly 
different between the first and second phases (11.5 vs 5.1%, 
p = 0.251). A second analysis tested the 47th case as a cut-
off point, but the risk of AL and clinical anastomotic fail-
ure remained stable in the second phase compared to the 
previous analysis (17% vs 5%, p = 0.056 and 8.9% vs 5%, 
p = 0.458, respectively).
Short‑ and long‑term oncological results
After TaTME, the pathological analysis showed a rate of 
distal margin involvement of 0% and a positive CRM rate of 
3.3%. The quality of the specimen was judged as complete/
near complete in 97.5% of cases. Excluding the two postop-
erative deaths, among 59 patients with a minimum follow-up 
of 24 months for survivors, the rate of recurrence was 18.6% 
(median DFS = 34 months), the rate of local recurrence was 
1.7%, the rate of distant recurrence was 18.6%, the rate of 
cancer-related mortality was 5.1%, and the rate of all-cause 
mortality was 11.8% (median OS = 35.1 months). None of 
the patients with local relapse presented a multifocal pat-
tern. CUSUM and RA-CUSUM curves for pathological and 
long-term results were not plotted because there were too 
few events.
Discussion
TaTME was introduced a decade ago as a surgical option for 
the treatment of rectal cancer to overcome some technical 
challenges in mesorectal dissection, particularly when sur-
gery is carried out through a minimally invasive approach 
for mid/low tumors in male or obese patients [7]. From the 
beginning of its introduction in surgical practice, TaTME 
has been claimed to be “the solution for old problems” and 
able to serve as a new dissection technique seemingly “much 
easier” than the transabdominal approach, performed open 
or laparoscopically [26]. Moreover, the rapid success of 
the TaTME procedure has been boosted by the conflicting 
results of the last RCTs unable to establish non-inferiority 
of the minimally invasive approach compared to the open 
approach in terms of pathological outcomes [5, 6]. In the 
competition between open, laparoscopic, and robotic TME, 
TaTME has emerged as a valid alternative combining the 
advantages of minimally invasive surgery from the abdomi-
nal side with optimal pathological results due to better visu-
alization of the pelvic field. As happens for every innova-
tive procedure, TaTME has generated many concerns from a 
technical point of view and from an oncological perspective. 
Performing the pelvic phase of the surgery from below 
changes both the anatomical view for dissection and the 
anastomotic technique, possibly exposing patients to unex-
pected complications and increasing the risk of anastomo-
sis. Furthermore, the distal transection of the rectal lumen 
inside the pelvis from the beginning of the procedure raised 
concerns about the oncological safety of TaTME because 
it may potentially expose the plane of dissection to cancer 
cells, no matter how tight the distal purse string [27]. The 
national experience of TaTME in Norway mirrored these 
concerns; higher than national rates of AL needing reopera-
tion (8.4%) and local recurrence with a multifocal pattern 
(11.6%) led to a national moratorium on TaTME [10]. The 
Norway report was based on 152 patients treated at 4 cent-
ers over 4 years, meaning that approximately 10 procedures 
were performed per center in a year. This report raised the 
question of whether the recurrence rate was due to the tech-
nique itself or whether it was a learning curve effect.
A recent report from the Netherlands [11] reported the 
local recurrence rate during the implementation of TaTME 
in a structured national training program. The authors 
pointed out that even if the surgeons were proctored, there 
was a clear learning curve effect in the first ten cases, with a 
recurrence rate of 10% and an AL rate of 17%, which were 
strictly correlated with the occurrence of intraoperative com-
plications. However, in the same study, the recurrence rate 
dropped to 3.8% after 40 procedures.
Excluding the Norway experience and despite the lack of 
high-level evidence supporting the benefits of TaTME, this 
technique has been widely adopted by colorectal surgeons 
across the world [28], and the good short- and long-term 
outcomes achieved at expert centers continuously support 
the implementation of this procedure in surgical practice.
Learning curve evaluation is one of the main areas of 
surgical research in TaTME, as it is such a complex surgi-
cal procedure. Identification of the learning phase of this 
technique is crucial because it allows recommendations for 
when and how to establish a training program to be made to 
avoid potential harm to patients and allow the supervision 
of surgeons not experienced in the technique.
To date, three studies focusing on the learning curve of 
TaTME have been published. Koedam et al. [13] reported 
on the learning curve in terms of the postoperative out-
comes in 138 patients treated with different surgical 
approaches, including a single- or double-team approach 
and approaches involving a single surgeon in the first 80 
cases and three surgeons afterward. The authors detected 
changes at the 40th, 100th, and 119th procedures and 
reported the 40th procedure as the primary cutoff, with a 
decrease in the MC rate from 47.5 to 17.5% and a decrease 
in the rate of AL from 27.5 to 5%. Instead, Lee et al. [14] 
focused on the quality of TaTME (including abdominop-
erineal resection) in 87 patients performed by 4 different 
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surgeons using a single-team approach. They reported 
high-quality TME in 95% of the patients and identified a 
turning point for high-quality TME at the 33rd procedure 
and optimization after the 45th-51st procedures.
More recently, in a study of 100 patients (85 with anas-
tomosis) treated by a single surgeon, Caycedo‐Marulanda 
et al. [15], reported 50 procedures as a turning point, provid-
ing a 50% improvement in the AL rate.
Overall, previous studies have reported long learning 
curves, pointing out the need for strict supervision in the 
first 40–50 cases.
This study presents a detailed learning curve analysis for 
TaTME. The analysis was based on a consecutive series of 
121 mid-low rectal cancer patients who underwent TaTME 
performed by the same surgical team who adopted TaTME 
in April 2015 without a structured training program. Since 
its introduction, TaTME has been considered the first choice 
for treating mid-low rectal cancer. Excluding the first 8 pro-
cedures, the double-team approach with a single surgeon 
performing the transanal procedure was considered the 
standard surgical procedure for mid-low rectal cancer.
The results showed a learning curve for OT consisting 
of three peaks, which could be considered three predict-
able turning points. The first peak, at the 18th procedure, 
represented the end of the first phase of learning the process 
of a new technique. The increase could be attributed to the 
switch to the double-team approach and to the upgrade of 
the OR setup and instrumentation. The second peak, at the 
54th procedure, could be considered the point at which pro-
ficiency is reached: the performance of the surgical team is 
optimized from a technical point of view. The third peak, at 
the 86th procedure, is apparently due to a case-mix effect or 
overconfidence in the procedure since it is consistent with 
the CUSUM curves for BMI, age high-risk patients under-
going TaTME during that period. Analyzing the two-sided 
Bernoulli CUSUM after the 71st procedure, the OT was 
more stable, without significant deviation from the mean. 
According to this trend, after the 71st procedure, the surgi-
cal team entered the “mastery” phase of the learning curve.
For MCs and reoperation, the learning curve presented 
three phases (1–54, 54–69, 70–121), all optimized after the 
69th case. This curve was consistent with the curves for 
postoperative complications and readmission. For AL, the 
learning curve presented two phases (1–27, 28–121), with 
the AL rate being optimized after the 27th case.
In the first phase of the respective learning curves, a rela-
tively higher risk of postoperative complications (46.3%), 
MCs (13%), and reoperation (9.3%) was detected. There 
were only two small alarm signals, one in the early phase 
for MCs and one in the early/middle phase for reoperation.
In the first phase of the learning curve (1–27), a high 
risk of AL (25.8%), coincident with an alarm signal, was 
detected. Nevertheless, most cases of AL were not clinically 
relevant and did not result in an equivalent risk of clinical 
anastomotic failure (11.5%).
Finally, the pathological and oncological results in terms 
of local recurrence in this case series are promising and 
consistent with those available from expert centers [9, 29], 
which provides reassurance that the technique is oncologi-
cally adequate and safe.
There are some relevant implications for the results of this 
study. The first is related to the observation that the initial 
phase of the learning curve was less safe in terms of postop-
erative complications and early and late AL. After the inflec-
tion point in the learning curve at the 27th case, the results 
for AL were acceptable and well below those reported in the 
literature [8, 9]. The anastomotic technique after TaTME 
is different from that after transabdominal rectal surgery. 
A radical change in the anastomotic technique is necessary 
after TaTME, and the results of this study reveal that this 
modification could be responsible for the high incidence of 
AL in the first phase. Fortunately, if we consider only the 
anastomotic complications resulting in a permanent stoma, 
the rate was 6.5%. Moreover, after the turning point, the AL 
rate significantly dropped and remained steadily low. Train-
ing programs, including tutoring and proctoring, should be 
implemented to mitigate the possible consequences of AL 
in this phase.
Second, the learning curves for the OT and postoperative 
outcomes were longer than that for AL, being optimized 
only after the 69th procedure. In the early phase, our postop-
erative outcomes were comparable to those in the literature, 
while in the middle and late phases, the rates of postopera-
tive outcomes were below those reported in the literature, 
codifying a learning curve effect on postoperative manage-
ment. The learning curve for these outcomes was probably 
longer than that of AL due to a shift in patient characteristics 
(i.e., more comorbidities) from the earlier to the later phases, 
as depicted in Supplementary Fig. 2s.
Third, the oncological outcomes of this study, albeit lim-
ited to less than half of the patients with adequate follow-up 
data, confirm that TaTME is a safe procedure for the treat-
ment of rectal cancer in terms of the pathological results and 
recurrence rate. These results are in line with those recently 
published in a large multicenter study on TaTME and the 
local recurrence rate after TaTME, which are in net contrast 
with the data from the Norwegian experience [29].
The main advantage of this study is that its cohort was 
homogeneous with regard to the indication for TaTME, the 
surgical technique and the composition of the surgical team. 
Second, we applied a statistical methodology using different 
types of CUSUM control charts to avoid confounding factors 
and self-referentiality and to explore all the possible impli-
cations of the learning process. This study also has some 
limitations. First, this analyzed data represent the experi-
ence of a team composed of surgeons extensively trained 
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in laparoscopic colorectal surgery at a high-volume center. 
Therefore, this curve may not be generalizable to all sur-
geons or institutions. Second, although this study included a 
reasonable number of procedures, a greater number of cases 
would be even more useful to identify oscillations in the 
surgical performance due to other causes (slight changes 
in the surgical technique, training of other surgeons) and to 
improve the quality of the O–E statistic-based regression 
analysis, which was limited from a few events in terms of 
MCs, reoperation, and AL/anastomotic failure.
Conclusions
The learning curve for the OT was optimized after the 71st 
procedure. The learning curve for MCs and reoperation was 
optimized after the 69th procedure, while the learning curve 
for AL was optimized after the 27th procedure. According 
to our data, the first phase of the learning curve is crucial, 
and without adequate training, will almost certainly expose 
patients to a high risk of serious postoperative complica-
tions. In expert hands, the oncological outcomes of TaTME 
seem not to be influenced by a learning curve effect.
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